Gene drive mosquitoes

Also known as Gene drive, CRISPR gene drive mosquitoes, Population-suppression gene drive

Gene drive mosquitoes are genetically edited mosquitoes designed to pass a population-reducing change to most of their offspring, with the aim of suppressing the malaria-carrying Anopheles population. The work so far is laboratory-based. A 2025 field programme in Burkina Faso, which used non-gene-drive modified mosquitoes, was halted by the government.

Research and prototypesDemonstratedReviewed 21 Oct 2026
AI illustration · Illustrative scene, not a photograph of the specific device or experiment.

In plain language

Malaria is spread by female Anopheles mosquitoes, which need blood to produce eggs. A gene drive is a genetic system that copies itself onto the matching chromosome, so far more of the offspring inherit the change than ordinary inheritance would allow. Researchers aim to use this to spread a trait that stops females from producing offspring, so that the mosquito population falls over several generations.

In laboratory cages, a gene drive built with CRISPR gene editing reached 100% prevalence in a major African malaria mosquito and caused the population to collapse within 7 to 11 generations. Those results come from closed cages. Wild mosquitoes move, feed and compete in complex ecosystems, and the researchers say that testing gene drive mosquitoes in the wild is still at least five to ten years away.

Technical explanation

The 2018 study by Kyrou, Hammond, Galizi and colleagues used CRISPR-Cas9 to target the doublesex gene in Anopheles gambiae. A drive construct aimed at this sequence spread rapidly in caged populations, reaching 100% prevalence within 7 to 11 generations and causing population collapse (Kyrou and colleagues, 2018).

Resistance is a main technical risk. Resistant alleles at the target site did not block the drive in the caged study. Whether this holds in wild populations, and whether drives can be contained or reversed if they spread beyond their target area, are open questions.

Field work has moved more slowly. Target Malaria, a project with partners in several African countries, reports a small-scale release of non-gene-drive genetically modified male-biased mosquitoes in Burkina Faso on 11 August 2025, carried out under national biosafety and environmental permits (Target Malaria, 2025). Authorities asked the project to suspend activities a week later, and the ministry announced the end of the project on 22 August 2025. The WHO Guidance Framework for Testing Genetically Modified Mosquitoes, second edition (2021), sets standards for developing, testing and regulating genetically modified mosquitoes. Its published description does not name gene drive.

What the evidence says

Each statement is typed by the strength of its evidence and linked to the source that supports it.

Demonstrated Shown in a published experiment, test or shipping product.

In caged Anopheles gambiae mosquitoes, a CRISPR-Cas9 gene drive targeting doublesex reached 100% prevalence and collapsed the population within 7 to 11 generations.

Sources: [1], [2] · Abstract; Imperial news release

Resistant alleles at the target site did not block the drive in the caged study.

Sources: [1] · Abstract (via Europe PMC record) · medium confidence

The 2018 results come from cage experiments, and the researchers say that larger, more realistic tropical trials are needed to test efficacy and stability, since competition for food and other ecological factors could change how a drive behaves.

Sources: [2] · Caveats section · medium confidence

The WHO guidance framework for testing genetically modified mosquitoes (second edition, 2021) sets standards for developing, testing and regulating these mosquitoes, but its published description does not mention gene drive.

Sources: [3] · Publication description

Reported, unverified Stated by a company or team but not independently confirmed.

Professor Andrea Crisanti said in 2018 that testing gene drive mosquitoes in the wild is at least five to ten years away.

Sources: [2] · Quoted statement from Crisanti · medium confidence

Target Malaria reports a small-scale release of non-gene-drive genetically modified male-biased mosquitoes in Burkina Faso on 11 August 2025, carried out under national biosafety and environmental permits.

Sources: [4] · Project update, release section · medium confidence

On 18 August 2025 national authorities asked the Target Malaria team at IRSS to suspend all activities, and on 22 August the Ministry of Higher Education, Research and Innovation announced that it had terminated all Target Malaria activities in the country.

Sources: [4] · Project update, suspension section · medium confidence

Limitations and open problems

  • The gene drive results come from laboratory cages, not from the wild. The lead researcher said in 2018 that at least five to ten years would pass before gene drive mosquitoes were tested in the wild.
  • Resistant alleles at the target site did not block the drive in the caged study. Whether this holds in wild populations is not known.
  • Ecological effects in the wild are not yet known. The Imperial team says larger, more realistic trials are needed, since competition for food and other ecological factors could change how a drive behaves.
  • Approval can be withdrawn: the Burkina Faso project was halted by the government in August 2025, after its non-gene-drive release.
  • The WHO testing framework is guidance and does not by itself decide whether any gene drive release is approved.

Possible future uses

Speculative

Ideas, not predictions. None of these has been demonstrated.

  • Gene drives that reduce malaria-carrying mosquito populations in African regions, used alongside bed nets, treatment and other control tools, if regulators and affected communities agree.
  • Gene drives aimed at other disease-carrying mosquitoes, such as Aedes species that spread dengue, once the Anopheles work has produced tested governance and safety models.
  • Reversal or containment systems that could limit a drive to a target area or remove it from a population if problems appear.

Timeline

  1. 24 Sept 2018Imperial College London announces that a CRISPR-Cas9 gene drive collapsed caged Anopheles gambiae populations within 7 to 11 generations, with Professor Andrea Crisanti saying wild testing is at least 5 to 10 years away. Sources: [2], [1]
  2. Dec 2018Kyrou, Hammond, Galizi and colleagues' paper 'A CRISPR-Cas9 gene drive targeting doublesex causes complete population suppression in caged Anopheles gambiae mosquitoes' appears in Nature Biotechnology volume 36, issue 11 (first published online 24 September 2018). Sources: [1]
  3. 19 May 2021WHO publishes the second edition of the Guidance framework for testing of genetically modified mosquitoes. Sources: [3]
  4. 11 Aug 2025Target Malaria reports a small-scale release of non-gene-drive genetically modified male-biased mosquitoes in Burkina Faso. Sources: [4]
  5. 22 Aug 2025Burkina Faso's Ministry of Higher Education, Research and Innovation announces that it has terminated all Target Malaria activities in the country. Sources: [4]

Futures this could help bring about

Related breakthroughs

Glossary

Gene drive
A genetic system that increases the chance that a gene is passed to offspring, so it can spread through a population faster than ordinary inheritance allows.
Population suppression
Reducing the size of a population, here a mosquito population, rather than replacing it with a modified one.
Anopheles gambiae
A mosquito species that is a major carrier of malaria in sub-Saharan Africa.
Resistant allele
A genetic variant that the gene drive cannot copy, which can stop the drive from spreading.

Sources

  1. peer reviewed paper
    A CRISPR-Cas9 gene drive targeting doublesex causes complete population suppression in caged Anopheles gambiae mosquitoes
    K. Kyrou, A. M. Hammond, R. Galizi et al.. Nature Biotechnology, 24 Sept 2018. DOI: 10.1038/nbt.4245. Accessed 21 Oct 2026.
  2. university press release
    Mosquitoes that can carry malaria eliminated in lab experiments
    Hayley Dunning. Imperial College London, 24 Sept 2018. Accessed 21 Oct 2026.
  3. other
    Guidance framework for testing of genetically modified mosquitoes, second edition
    World Health Organization, 19 May 2021. Accessed 21 Oct 2026.
  4. other
    Target Malaria activities suspended in Burkina Faso
    Target Malaria, 22 Aug 2025. Accessed 21 Oct 2026.

Revision history

3 changes since this profile was created.

Changes on 21 Oct 2026
Published on owner instruction (content loop iteration 26)743f5cc
Sources and claims re-checked against originalsfbb434c
Initial profile drafted from primary sources7e66249